Evidence map›Paper›PMID 41837626›Full record

ArticlemSystems2026

Comparative genomic analyses of

Nam-Hoon Kim, Jung Hun Lee, Saba Yasmin, Abdul Rauf Tareen, Kyung-Min Jang, Chanyeong Jeong, Byeonghyeon Kang, Gwangje Lee, Dong-Won Lee, Rabaab Zahra and 2 more

Abstract readComparative Study
In one paragraph

Article in mSystems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nam-Hoon Kim *Department of Life Sciences, Jeonbuk National University, Jeonju, South Korea.
Jung Hun Lee *National Leading Research Laboratory of Drug Resistance Proteomics, Department of Biological Sciences, Myongji University, Yongin, South Korea.
Saba YasminDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Abdul Rauf TareenDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Kyung-Min JangNational Leading Research Laboratory of Drug Resistance Proteomics, Department of Biological Sciences, Myongji University, Yongin, South Korea.
Chanyeong JeongNational Leading Research Laboratory of Drug Resistance Proteomics, Department of Biological Sciences, Myongji University, Yongin, South Korea.
Byeonghyeon KangNational Leading Research Laboratory of Drug Resistance Proteomics, Department of Biological Sciences, Myongji University, Yongin, South Korea.
Gwangje LeeNational Leading Research Laboratory of Drug Resistance Proteomics, Department of Biological Sciences, Myongji University, Yongin, South Korea.
Dong-Won LeeDepartment of Life Sciences, Jeonbuk National University, Jeonju, South Korea.
Rabaab ZahraDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Dae-Wi KimDepartment of Life Sciences, Jeonbuk National University, Jeonju, South Korea.ORCID 0000-0002-5208-300X
Sang Hee LeeNational Leading Research Laboratory of Drug Resistance Proteomics, Department of Biological Sciences, Myongji University, Yongin, South Korea.ORCID 0000-0002-5660-7122

Funding

National Research Foundation of Korea RS-2024-00443714National Research Foundation of Korea RS-2026-25470080
6 · The paper itself

Abstract

IMPORTANCE: This study provides a comprehensive genomic landscape of ST405, a high-risk international clone and a carrier of the

Indexed as

Escherichia coliGenome, BacterialGenomicsAnimalsAnti-Bacterial Agentsbeta-LactamasesBirdsDrug Resistance, Multiple, BacterialEscherichia coli InfectionsFecesPakistanPhylogenyPlasmidsSewageAnti-Bacterial Agentsbeta-LactamasesSewageblaNDM-5comparative genomicshigh-risk cloneIS26plasmidST405

Identifiers

PMID41837626
PMCPMC13098264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.